).
femoral artery (CFA) after p-EVAR. In 1997, Diethrich 14 and, several years later, Larzon et al 15 were the pioneers, who described the method as minimal access suture technique of the cribriform fascia "fascia closure"; however, it is still not widely adopted.
An alternative surgical option that has been described after the recent advances in stent graft technology (reduction of stent-graft delivery profile) refers to suturemediated closure devices (SMCDs). 16, 17 Perclose Prostar XL (Abbott Vascular, Redwood City, CA) is the main device available for percutaneous closure of large bore arterial access sheath. Although, Prostar XL was the only device with formal approval for use in EVAR, several authors have used the Proglide system (Abbott Vascular, Redwood City, CA) off-label in daily clinical practice until April 2013.
18,19
Thereafter, the Proglide system is approved for 5 F to 21 F closure, with double Proglide use required for larger than 8 F sheaths. The primary aim of this article was to determine the efficacy and safety of the FST and SMCDs regarding closing CFA punctures after p-EVAR. All the available data from prospective, retrospective, and randomized controlled trials that reported loco-regional complications have also been evaluated in this systematic review.
Methods Search Strategy, Data Sources, and Eligibility Criteria
A systematic review was conducted in accordance to the Preferred Reporting Items for Systematic reviews and MetaAnalysis (PRISMA) guidelines. A study protocol was agreed upon and was strictly followed by all authors. Identification of eligible studies was performed using three distinct databases through December 2016: Medline, ClinicalTrials.gov, and Cochrane library -Cochrane Central Register of Controlled Trials (CENTRAL). The following MeSH terms were utilized in various combinations: "Suture-mediated closure devices" and "Fascia Suture Technique." and the keywords "Percutaneous endovascular aneurysm repair (p-EVAR)" and "Femoral Artery Access Sites." Moreover, the reference lists of all included articles were examined manually for further references. All studies were independently assessed by two investigators (Georgios Karaolanis and Konstantinos G. Moulakakis), and the full texts of the studies were retrieved.
Studies were included in the present review if:
• They provided results referring to SMCDs that involved only the Prostar XL and/or Proglide closure devices.
• They provided results referred to FST.
• A series of at least 10 patients were studied.
Articles were excluded if:
• They were referring also to other SMCDs other than Prostar XL and/ or Proglide closure devices.
• They provided data of the SMCDs use in other surgical fields other than the vascular.
• Narrative reviews described the FST and the SMCDs without elaboration data.
Prospective, retrospective, and randomized trials were included, but letters, reviews, and non-English language articles were excluded. We sought to review all updates on the subject after the introduction of the FST in the treatment armamentarium.
As primary outcomes, technical success rate and locoregional complications using both closure techniques (FST/ SMCDs) were considered. Secondary outcomes assessed were operative time, hospital stay, and time to ambulation in the SMCDs group. In the FST group, short-( 30 days) and long-term (>30 days and within 12 months) complications were also classified as secondary outcomes.
Definitions
The definition of technical success was not uniform across all studies in the SMCDs group. [16] [17] [18] We attempted to standardize technical success as the ability to obtain hemostasis at the access site without the need for surgical cut down.
On the other hand, in the FST group, technical success was defined as the achievement of hemostasis with adequate distal perfusion within the first 24 hours without femoral occlusion or use of additional fascial sutures. 15,46-50 Any complication (bleeding and/or thrombosis) that leads to additional procedure within 24 hours was classified as intraoperative complication, whereas complications, such as bleeding, thrombosis, pseudoaneurysm, stenosis, neuralgia, seroma, and local infection, that took place after 24 hours were considered postoperative.
Fascia Suture Technique
Under general, spinal, or local anesthesia, puncture of the femoral artery just below the inguinal ligament and after its identification either palpably, through duplex or through computed tomography angiography (CTA), is performed. The next step after the completion of any endovascular procedure is the fascia closure. This procedure requires the introducer with the dilator and the guide wire to remain in place. First, the skin incision at the introducer insertion site is extended either transversally by 4 to 8 cm 15 studies included only cases with SMCDs. The effectiveness of the Proglide system was evaluated in four studies, 18, 28, 29, 42 whereas the outcomes of the two SMCDs were compared and described in two studies. 
Results of SMCD
The two types of SMCD that were used in the reviewed studies were Prostar XL and the Proglide system. Prostar XL was used in 27 studies, 16, 17, [20] [21] [22] [23] [24] [25] [26] [27] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [43] [44] [45] [46] and Proglide was used in 6 studies. 18, 20, [27] [28] [29] 42 In three studies, 20, 27, 29 both Prostar and Proglide devices were used. The rates of technical success by access site ranged between 63 Review of FST and SMCD Karaolanis et al. 15
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and 100%, but with only two articles 34,37 reporting rates below 80% and most articles [16] [17] [18] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] 35, 36, [38] [39] [40] [41] [42] [43] [44] [45] [46] reporting rates between 89 and 100%. 
Results of FST
The technical success rates were high, ranging between 87 and 99%. The rates of intraoperative complications ranged between 1.2 and 13%, whereas the rates of short-term complications, within 30 days from the operation, were from 0.9 up to 6.2%. Similar were the rates of long-term complications >30 days from the operation, which varied between 1.9 and 13.6%. attempted to compare FST with SMCD. In particular, median access closure time was shorter with the FST than the Prostar XL Device (12.4 min versus 19.9 min, p < 0.001), but no significant differences were detected between FST and SMCD in regards to the rates of technical failure, complications, or reintervention. In addition, there was a decrease in cost by €800 when FST was used (p < 0.001).
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Discussion
In all fields of surgery, there is a trend toward less invasive procedures, aiming at reducing hospital stay, complications, and mortality. In our analysis, the technical success rate ranges between 89 and 100%, whereas the loco-regional complications were calculated between 0 and 25%. Our results are absolutely consistent with two recently published studies. 53, 54 In the first study, 53 the use of the Prostar XL device has indicated overall good results for the percutaneous techniques with a weighted average success rate of 91% (87-95%) in the same time that regarding local complications a risk ratio of 0.87 (95% confidence interval [CI]) in favor of p-EVAR over surgical access was found a lower risk which nevertheless did not reach statistical significance. In the second study, 54 the reported technical success in p-EVAR group was 92%, whereas the local complications were reported lower in the group undergoing percutaneous access (risk ratio, 0.47; 95% CI). In the same time, the aforementioned studies revealed that p-EVAR compared with s-EVAR seemed advantageous in terms of reduced procedural time, hospital stay, and time to ambulation in comparison. These results were confirmed in our study (►Tables 1 and 2) with the mean operative time to be 86.7 to 180 min, the hospital stay 1.3 to 6.7 days, and mean time to ambulation 17 to 24 hours. To minimize the groin complication, rates should be considered in the context of patient selection for p-EVAR. As demonstrated in most series, and to be eligible for p-EVAR, patients had to meet certain anatomical criteria. 160-sutured fascial cases, where CFA were assessed with preoperative fluoroscopic guidance. In this study, there were no anatomical exclusion criteria such as high bifurcation of the CFA, and the thickness of the fat overlying the CFA did not compromise the success of the technique. In the same period, Mathisen et al. 49 reviewed their results in a retrospective study, which included 49 patients (81 femoral access sites). The CFA was detected using palpation. It is worth mentioning that in these later studies, plaque/calcification did not appear to influence the success of fascia closure, as it was reported with the SMCD. [23] [24] [25] [26] [27] A new attempt to evaluate the technical success was made by Dziekiewicz et al. 50 In this study, 58
patients (116 CFA) were included, whose CFA were detected preoperatively using a CTA. Recently, we published our experience with the results to be acceptable. 48 Primary and secondary technical success rates were high with 96.1 and 100%, respectively, and with low short-and mid-term technical failures. The other finding of our analysis was that p-EVAR using FST reported a technical success between 87 and 99%. Most shortterm complications (0.9-6.2%) associated with the technique, such as dissection, pseudoaneurysm formation, arterial stenosis, and ischemia, could be identified using handheld Doppler in the operation room and a duplex scan postoperatively. Moreover, perioperative bleeding could be tackled immediately by reintroducing the sheath over the retained guidewire and putting additional sutures if needed. Long-term complications (1.9-13.6%), such as arterial stenosis or pseudoaneurysms were faced either surgically or conservatively. Therefore, we judged the technique as safe, effective, and durable with a quite short learning curve. Moreover, FST seems to offer a "notouch" artery closure, which could be advantageous in case of endovascular treatment of ruptured aortic aneurysms. 52 The lack of the preclosure preparation of the access site seems to be advantageous under these critical situations. Furthermore, as demonstrated in the Larzon et al's study, 52 FST can work as a bailout procedure for failed Prostar XL suture. In the same study, there was an attempt to investigate whether FST can reduce the access closure time and the procedural costs compared with the Prostar XL technique. 52 The FST was raised as faster (median closure time 12.4 min) than Prostar (median closure time 19.9 min), but the main reason why the FST was significantly cheaper was the reduction in material costs. There was a significant cost difference in favor of FST, with a median difference of €800. On the other hand, FST presents two weak points that the vascular surgeon must keep in mind for successful outcomes. First, not all patients have an anatomically distinct femoral fascia, especially on the medial side. Weakness of the femoral fascia may cause leakage and difficulty in suture sealing. Second, optimal puncture site below the inguinal ligament and above the femoral bifurcation represents the cornerstone for a successful FST. A puncture above the inguinal ligament may make the femoral closure less effective, as the femoral fascia is not appropriate for the coverage of the artery wall, and retroperitoneal bleeding may occur. In addition, low puncture close to the deep femoral artery (DFA) might also lead to the same complication and cause hemorrhage in the groin.
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To the best of our knowledge, this is the first study that collect overall data from the FST and SMCDs studies after p-EVAR. However, the study presents some limitations. First, the nature of p-EVAR and FST studies that include only three randomized controlled trial. Furthermore, the reviewed studies presented some differences with regard to the type of endovascular procedure, the indication for the treatment, the type of closure device used, and the duration of followup. All studies failed to provide clear guidelines when SMCDs and FST were useful under significant confounders, such as vascular calcification, obesity, groin scarring, etc. Moreover, the outcome was described with relevant terms, such as technical success and failure. Further studies with a large number of patients are necessary to compare the two techniques and to extract essential and safe conclusions.
Conclusions
SMCDs and FST seem to be effective and simple methods for closing CFA punctures after p-EVAR. The techniques seem to be applicable to all patients, even in emergency procedures, whereas the few failures that may occur due to bleeding or occlusion can easily be managed. Particular caution is needed when clinicians perform p-EVAR using SMCDs where their experience and familiarity with the devices remain significant predictors of success. FST can reduce the access closure time and the procedural costs with a quite short learning curve, still the results remain controversial due to the limited number of published studies.
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